0001415889-22-012041.txt : 20221205 0001415889-22-012041.hdr.sgml : 20221205 20221205161020 ACCESSION NUMBER: 0001415889-22-012041 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221202 FILED AS OF DATE: 20221205 DATE AS OF CHANGE: 20221205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Serafin Andrew CENTRAL INDEX KEY: 0001821460 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39450 FILM NUMBER: 221445041 MAIL ADDRESS: STREET 1: 630 W. GERMANTOWN PIKE CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc. CENTRAL INDEX KEY: 0001802665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822279923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: (484) 539-9800 MAIL ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 4 1 form4-12052022_041201.xml X0306 4 2022-12-02 0001802665 Harmony Biosciences Holdings, Inc. HRMY 0001821460 Serafin Andrew C/O HARMONY BIOSCIENCES HOLDINGS, INC. 630 W GERMANTOWN PIKE, SUITE 215 PLYMOUTH MEETING PA 19462 false true false false CHIEF STRATEGY OFFICER Common Stock 2022-12-02 4 M 0 38000 8.22 A 38000 D Common Stock 2022-12-02 4 S 0 37080 60.1199 D 920 D Common Stock 2022-12-02 4 S 0 920 60.7109 D 0 D Stock Option 8.22 2022-12-02 4 M 0 38000 0 D 2027-10-01 Common Stock 38000 83729 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.67 to $60.66. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.67 to $60.77. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock options vests in five equal annual installments beginning on October 1, 2018. /s/ Christian Ulrich, Attorney-in-Fact 2022-12-05